IGF2BP1 and colorectal carcinoma: Further mechanistic studies suggested that LOC101928222 synergizes with IGF2BP1 to stabilize HMGCS2 mRNA via a METTL16-mediated m6A-dependent pathway, leading to increased cholesterol synthesis, and, consequently, the promotion of CRC development.